Real-time enrollment status for this relapsed/refractory acute myeloid leukemia (aml) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:50 AM UTC
| NCT Number | NCT07613385 |
| Recruiting Status | Recruiting |
| Condition | Relapsed/Refractory Acute Myeloid Leukemia (AML) |
| Phase | Clinical Trial |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | June 15, 2026 (4 weeks ago) |
As of July 13, 2026: Clinical trial NCT07613385 is currently recruiting participants. This clinical trial study for relapsed/refractory acute myeloid leukemia (aml) is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07613385 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07613385 was last updated 4 weeks ago (June 15, 2026). HelloStudys verifies this status automatically.